Comparing accuracy in an unpaired post-market device study with incomplete disease assessment

Biometrical Journal

Volumn 51, Issue 3, 2009, Pages 491-503

  Alonzo, Todd A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Inverse probability weighting; Sample size; Sensitivity; Specificity; Verification bias

Indexed keywords

CONFIDENCE INTERVAL; GOLD STANDARDS; INVERSE PROBABILITY WEIGHTING; MEDICAL DEVICES; PROBABILITY WEIGHTING; SAMPLE SIZES; SENSITIVITY; SENSITIVITY AND SPECIFICITY; SPECIFICITY; VERIFICATION BIAS;

BIOMEDICAL EQUIPMENT;

EID: 68249110469     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200800159     Document Type: Article

References (13)

1. Alonzo, T. A. and Kittelson, J. M. (2006). A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible. Biometrics 62, 605-612.
2. Alonzo, T. A., Pepe, M. S. and Moskowitz, C. S. (2002). Sample size calculations for comparative studies of medical tests for detecting presence of disease. Statistics in Medicine 21, 835-852.
3. Begg, C. B. and Greenes, R. A. (1983). Assessment of diagnostic tests when disease is subject to selection bias. Biometrics 39, 207-216.
4. Horvitz, D. G. and Thompson, D. J. (1951). A generalization of sampling without replacement from a finite universe. Journal of the American Statistical Association 47, 663-685.
5. Kondratovich, M. V. (2008). Comparing two medical tests when results of reference standard are unavailable for those negative via both tests. Journal of Biopharmaceutical Statistics 18, 145-166.
6. Little, R. J. and Rubin, D. B. (1987). Statistical Analysis with Missing Data. Wiley, New York.
7. McCrory, D. C., Matchar, D. B., Bastian, L., Datta, S., Hasselblad, V., Hickey, J., Myers, E., and Nanda, K. (1999). Evaluation of Cervical Cytology. Evidence Report/Technology Assessment No. 5. AHCPR Publication No. 99-E0101, Rockville, MD.
8. McNamee, R. (2002). Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value. Statistics in Medicine 21, 3609-3625.
9. Pepe, M. S. (2003). The Statistical Evaluation of Medical Diagnostic Tests for Classification and Prediction. Oxford University Press, Oxford.
10. Pepe, M. S. and Alonzo T. A. (2001). Comparing disease screening tests when true disease status is ascertained only for screen positives. Biostatistics 2, 249-260.
11. Ransohoff, D. F. and Feinstein, A. R. (1978). Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. New England Journal of Medicine 299, 926-930.
12. Ries, L. A. G., Melbert, D., Krapcho, M., Stinchcomb, D. G., Howlader, N., Horner, M. J., Mariotto, A., Miller, B. A., Feuer, E. J., Altekruse, S. F., Lewis, D. R., Clegg, L., Eisner, M. P., Reichman, M. and Edwards, B. K. (2008). SEER Cancer Statistics Review, 1975-2005 National Cancer Institute, Bethesda, MD.
13. Simel, D. L., Samsa, G. P. and Matchar, D. B. (1991). Likelihood ratios with confidence: sample size estimation for diagnostic test studies. Journal of Clinical Epidemiology 44, 763-770.